RTW INVESTMENTS, LP - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2022$3,337,000
-14.5%
490,0000.0%0.09%
+6.2%
Q1 2022$3,905,000
+42.3%
490,0000.0%0.08%
+102.5%
Q4 2021$2,744,000
-27.2%
490,0000.0%0.04%
-29.8%
Q3 2021$3,768,000490,0000.06%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,560,984$27,526,0006.63%
Fairmount Funds Management LLC 2,833,950$21,906,0003.85%
JOHNSON & JOHNSON 1,000,000$7,730,0002.28%
BVF INC/IL 5,590,048$43,211,0001.78%
Affinity Asset Advisors, LLC 746,576$5,771,0001.61%
Sio Capital Management, LLC 544,545$4,209,0001.34%
PFM Health Sciences, LP 4,515,216$34,903,0001.26%
SPHERA FUNDS MANAGEMENT LTD. 1,052,842$8,138,0001.13%
Boxer Capital, LLC 2,500,000$19,325,0001.09%
SILVERARC CAPITAL MANAGEMENT, LLC 300,000$2,319,0000.78%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders